Table 2.

Correlation between BOLA2 protein and clinicopathological characteristics in 175 HCC patients

Clinical and pathological variable		BOLA2 protein
		Low expression (n=57)	High expression (n=118)	P value
Age, years	≤60	36	64	0.264
	>60	21	54
Sex	Male	47	86	0.165
	Female	10	32
Child-Pugh score	A	38	93	0.083
	B	19	25
Albumin, g/L	≤35	9	11	0.208
	>35	48	107
AFP, (ng/mL)	≤200	26	41	0.258
	>200	31	71
Liver cirrhosis	Absent	10	12	0.168
	Present	47	106
Tumor size, (cm)	≤5	24	36	0.130
	>5	33	82
Tumor number	Single	36	57	0.065
	Multiple	21	61
Tumor encapsulation	Complete	23	39	0.344
	None	34	79
Satellite nodules	Absent	42	33	<0.0001
	Present	15	85
Venous invasion	Absent	37	27	<0.0001
	Present	20	91
Tumor differentiation	I-II	9	49	0.001
	III-IV	48	69
Tumor hemorrhage	Absent	27	30	0.004
	Present	30	88
BCLC stage	A	31	35	0.002
	B-C	26	83
TNM stage	I	26	29	0.005
	II-III	31	89

A significant difference is shown in bold.